-
1
-
-
0032900953
-
Biochemical, cellular, and pharmacological aspects of the multidrug transporter
-
DOI 10.1146/annurev.pharmtox.39.1.361
-
SV Ambudkar S Dey CA Hrycyna M Ramachandra I Pastan MM Gottesman 1999 Biochemical, cellular, and pharmacological aspects of the multidrug transporter Annu Rev Pharmacol Toxicol 39 361 398 1:CAS:528:DyaK1MXjtVejtLo%3D 10.1146/annurev.pharmtox.39.1.361 10331089 (Pubitemid 29222564)
-
(1999)
Annual Review of Pharmacology and Toxicology
, vol.39
, pp. 361-398
-
-
Ambudkar, S.V.1
Dey, S.2
Hrycyna, C.A.3
Ramachandra, M.4
Pastan, I.5
Gottesman, M.M.6
-
2
-
-
0033250545
-
Multidrug-resistance transporters
-
1:CAS:528:DC%2BD3cXkslylurc%3D 10.1007/0-306-46812-3-13 10742982
-
JA Silverman 1999 Multidrug-resistance transporters Pharm Biotechnol 12 353 386 1:CAS:528:DC%2BD3cXkslylurc%3D 10.1007/0-306-46812-3-13 10742982
-
(1999)
Pharm Biotechnol
, vol.12
, pp. 353-386
-
-
Silverman, J.A.1
-
3
-
-
34250177984
-
The blood-brain barrier and cancer: Transporters, treatment, and trojan horses
-
DOI 10.1158/1078-0432.CCR-06-2854
-
JF Deeken W Loscher 2007 The blood-brain barrier and cancer: transporters, treatment, and Trojan horses Clin Cancer Res 13 6 1663 1674 1:CAS:528:DC%2BD2sXivV2gtrg%3D 10.1158/1078-0432.CCR-06-2854 17363519 (Pubitemid 46952931)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.6
, pp. 1663-1674
-
-
Deeken, J.F.1
Loscher, W.2
-
4
-
-
43449133278
-
Resistance to chemotherapy in cancer: A complex and integrated cellular response
-
DOI 10.1159/000115967
-
HR Mellor R Callaghan 2008 Resistance to chemotherapy in cancer: a complex and integrated cellular response Pharmacology 81 4 275 300 1:CAS:528:DC%2BD1cXlsFOgs70%3D 10.1159/000115967 18259091 (Pubitemid 351666917)
-
(2008)
Pharmacology
, vol.81
, Issue.4
, pp. 275-300
-
-
Mellor, H.R.1
Callaghan, R.2
-
5
-
-
4644353500
-
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 1: Cellular pharmacology, in vitro and initial in vivo antitumor activity
-
DOI 10.1158/0008-5472.CAN-03-2941
-
JA Hartley VJ Spanswick N Brooks PH Clingen PJ McHugh D Hochhauser, et al. 2004 SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity Cancer Res 64 18 6693 6699 1:CAS:528:DC%2BD2cXnsFOksrw%3D 10.1158/0008-5472.CAN-03-2941 15374986 (Pubitemid 39297932)
-
(2004)
Cancer Research
, vol.64
, Issue.18
, pp. 6693-6699
-
-
Hartley, J.A.1
Spanswick, V.J.2
Brooks, N.3
Clingen, P.H.4
McHugh, P.J.5
Hochhauser, D.6
Pedley, R.B.7
Kelland, L.R.8
Alley, M.C.9
Schultz, R.10
Hollingshead, M.G.11
Schweikart, K.M.12
Tomaszewski, J.E.13
Sausville, E.A.14
Gregson, S.J.15
Howard, P.W.16
Thurston, D.E.17
-
6
-
-
0035282633
-
Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity
-
DOI 10.1021/jm001064n
-
SJ Gregson PW Howard JA Hartley NA Brooks LJ Adams TC Jenkins, et al. 2001 Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity J Med Chem 44 5 737 748 1:CAS:528:DC%2BD3MXmvVOisA%3D%3D 10.1021/jm001064n 11262084 (Pubitemid 32171670)
-
(2001)
Journal of Medicinal Chemistry
, vol.44
, Issue.5
, pp. 737-748
-
-
Gregson, S.J.1
Howard, P.W.2
Hartley, J.A.3
Brooks, N.A.4
Adams, L.J.5
Jenkins, T.C.6
Kelland, L.R.7
Thurston, D.E.8
-
7
-
-
77649192721
-
A phase i trial of SJG-136 (NSC#694501) in advanced solid tumors
-
1:CAS:528:DC%2BC3cXit1GmtL0%3D 10.1007/s00280-009-1088-4 19672598
-
YY Janjigian W Lee MG Kris VA Miller LM Krug CG Azzoli, et al. 2010 A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors Cancer Chemother Pharmacol 65 5 833 838 1:CAS:528:DC%2BC3cXit1GmtL0%3D 10.1007/s00280-009-1088-4 19672598
-
(2010)
Cancer Chemother Pharmacol
, vol.65
, Issue.5
, pp. 833-838
-
-
Janjigian, Y.Y.1
Lee, W.2
Kris, M.G.3
Miller, V.A.4
Krug, L.M.5
Azzoli, C.G.6
-
8
-
-
4644316457
-
SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations
-
DOI 10.1158/0008-5472.CAN-03-2942
-
MC Alley MG Hollingshead CM Pacula-Cox WR Waud JA Hartley PW Howard, et al. 2004 SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 2: efficacy evaluations Cancer Res 64 18 6700 6706 1:CAS:528:DC%2BD2cXnsFOksr0%3D 10.1158/0008-5472.CAN-03-2942 15374987 (Pubitemid 39297933)
-
(2004)
Cancer Research
, vol.64
, Issue.18
, pp. 6700-6706
-
-
Alley, M.C.1
Hollingshead, M.G.2
Pacula-Cox, C.M.3
Waud, W.R.4
Hartley, J.A.5
Howard, P.W.6
Gregson, S.J.7
Thurston, D.E.8
Sausville, E.A.9
-
9
-
-
23644457140
-
Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136
-
DOI 10.1016/j.ejca.2005.04.026, PII S0959804905004259
-
SM Guichard JS Macpherson DE Thurston DI Jodrell 2005 Influence of P-glycoprotein expression on in vitro cytotoxicity and in vivo antitumour activity of the novel pyrrolobenzodiazepine dimer SJG-136 Eur J Cancer 41 12 1811 1818 1:CAS:528:DC%2BD2MXns1WitLw%3D 10.1016/j.ejca.2005.04.026 16046116 (Pubitemid 41132645)
-
(2005)
European Journal of Cancer
, vol.41
, Issue.12
, pp. 1811-1818
-
-
Guichard, S.M.1
Macpherson, J.S.2
Thurston, D.E.3
Jodrell, D.I.4
-
10
-
-
77950584653
-
Structure-activity relationships of monomeric C2-aryl pyrrolo[2, 1-c][1, 4]benzodiazepine (PBD) antitumor agents
-
1:CAS:528:DC%2BC3cXjtVygsLs%3D 10.1021/jm901722v 20218628
-
D Antonow M Kaliszczak GD Kang M Coffils AC Tiberghien N Cooper, et al. 2010 Structure-activity relationships of monomeric C2-aryl pyrrolo[2, 1-c][1, 4]benzodiazepine (PBD) antitumor agents J Med Chem 53 7 2927 2941 1:CAS:528:DC%2BC3cXjtVygsLs%3D 10.1021/jm901722v 20218628
-
(2010)
J Med Chem
, vol.53
, Issue.7
, pp. 2927-2941
-
-
Antonow, D.1
Kaliszczak, M.2
Kang, G.D.3
Coffils, M.4
Tiberghien, A.C.5
Cooper, N.6
-
11
-
-
33846963786
-
Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119)
-
1:CAS:528:DC%2BD2sXislSgsrc%3D 17309854
-
AM Burger PM Loadman DE Thurston R Schultz HH Fiebig MC Bibby 2007 Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119) J Chemother 19 1 66 78 1:CAS:528:DC%2BD2sXislSgsrc%3D 17309854
-
(2007)
J Chemother
, vol.19
, Issue.1
, pp. 66-78
-
-
Burger, A.M.1
Loadman, P.M.2
Thurston, D.E.3
Schultz, R.4
Fiebig, H.H.5
Bibby, M.C.6
-
13
-
-
63449133609
-
Phase i study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors
-
1:CAS:528:DC%2BD1MXjtF2rurg%3D 10.1158/1078-0432.CCR-08-1315 19276288
-
D Hochhauser T Meyer VJ Spanswick J Wu PH Clingen P Loadman, et al. 2009 Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors Clin Cancer Res 15 6 2140 2147 1:CAS:528:DC%2BD1MXjtF2rurg%3D 10.1158/1078-0432.CCR-08-1315 19276288
-
(2009)
Clin Cancer Res
, vol.15
, Issue.6
, pp. 2140-2147
-
-
Hochhauser, D.1
Meyer, T.2
Spanswick, V.J.3
Wu, J.4
Clingen, P.H.5
Loadman, P.6
-
14
-
-
34249935509
-
Parallel synthesis of a novel C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) library
-
1:CAS:528:DC%2BD2sXjs1Sktb0%3D 10.1021/cc0601332 17397227
-
D Antonow N Cooper PW Howard DE Thurston 2007 Parallel synthesis of a novel C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine (PBD) library J Comb Chem 9 3 437 445 1:CAS:528:DC%2BD2sXjs1Sktb0%3D 10.1021/cc0601332 17397227
-
(2007)
J Comb Chem
, vol.9
, Issue.3
, pp. 437-445
-
-
Antonow, D.1
Cooper, N.2
Howard, P.W.3
Thurston, D.E.4
-
15
-
-
0035814023
-
Synthesis of the first example of a C2-C3/C2'-C3'-endo unsaturated pyrrolo[2, 1-c][1, 4]benzodiazepine dimer
-
1:CAS:528:DC%2BD3MXnsVKls7w%3D 10.1016/S0960-894X(01)00560-1 11597416
-
SJ Gregson PW Howard KE Corcoran TC Jenkins LR Kelland DE Thurston 2001 Synthesis of the first example of a C2-C3/C2'-C3'-endo unsaturated pyrrolo[2, 1-c][1, 4]benzodiazepine dimer Bioorg Med Chem Lett 11 21 2859 2862 1:CAS:528:DC%2BD3MXnsVKls7w%3D 10.1016/S0960-894X(01)00560-1 11597416
-
(2001)
Bioorg Med Chem Lett
, vol.11
, Issue.21
, pp. 2859-2862
-
-
Gregson, S.J.1
Howard, P.W.2
Corcoran, K.E.3
Jenkins, T.C.4
Kelland, L.R.5
Thurston, D.E.6
-
16
-
-
0021815179
-
Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine
-
1:CAS:528:DyaL2MXktF2itb8%3D 3986765
-
KG Louie BC Behrens TJ Kinsella TC Hamilton KR Grotzinger WM McKoy, et al. 1985 Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine Cancer Res 45 5 2110 2115 1:CAS:528:DyaL2MXktF2itb8%3D 3986765
-
(1985)
Cancer Res
, vol.45
, Issue.5
, pp. 2110-2115
-
-
Louie, K.G.1
Behrens, B.C.2
Kinsella, T.J.3
Hamilton, T.C.4
Grotzinger, K.R.5
McKoy, W.M.6
-
17
-
-
0026496549
-
Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells
-
1:CAS:528:DyaK3sXjt1KgtQ%3D%3D 1358431
-
M Nakagawa E Schneider KH Dixon J Horton K Kelley C Morrow, et al. 1992 Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells Cancer Res 52 22 6175 6181 1:CAS:528:DyaK3sXjt1KgtQ%3D%3D 1358431
-
(1992)
Cancer Res
, vol.52
, Issue.22
, pp. 6175-6181
-
-
Nakagawa, M.1
Schneider, E.2
Dixon, K.H.3
Horton, J.4
Kelley, K.5
Morrow, C.6
-
18
-
-
0025341331
-
New colorimetric cytotoxicity assay for anticancer-drug screening
-
1:CAS:528:DyaK3cXltVylsL8%3D 10.1093/jnci/82.13.1107 2359136
-
P Skehan R Storeng D Scudiero A Monks J McMahon D Vistica, et al. 1990 New colorimetric cytotoxicity assay for anticancer-drug screening J Natl Cancer Inst 82 13 1107 1112 1:CAS:528:DyaK3cXltVylsL8%3D 10.1093/jnci/82.13.1107 2359136
-
(1990)
J Natl Cancer Inst
, vol.82
, Issue.13
, pp. 1107-1112
-
-
Skehan, P.1
Storeng, R.2
Scudiero, D.3
Monks, A.4
McMahon, J.5
Vistica, D.6
-
19
-
-
0025804183
-
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
-
1:CAS:528:DyaK3MXhslOrt7c%3D 10.1016/0006-291X(91)91647-U 1673839
-
P Artursson J Karlsson 1991 Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells Biochem Biophys Res Commun 175 3 880 885 1:CAS:528:DyaK3MXhslOrt7c%3D 10.1016/0006-291X(91)91647-U 1673839
-
(1991)
Biochem Biophys Res Commun
, vol.175
, Issue.3
, pp. 880-885
-
-
Artursson, P.1
Karlsson, J.2
-
21
-
-
0024593744
-
Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
-
1:STN:280:DyaL1M7itFeqsg%3D%3D 2914637
-
IJ Hidalgo TJ Raub RT Borchardt 1989 Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability Gastroenterology 96 3 736 749 1:STN:280:DyaL1M7itFeqsg%3D%3D 2914637
-
(1989)
Gastroenterology
, vol.96
, Issue.3
, pp. 736-749
-
-
Hidalgo, I.J.1
Raub, T.J.2
Borchardt, R.T.3
-
22
-
-
20144385483
-
Rational selection of structurally diverse natural product scaffolds with favorable ADME properties for drug discovery
-
DOI 10.1007/s11030-005-1297-7
-
DS Samiulla VV Vaidyanathan PC Arun G Balan M Blaze S Bondre, et al. 2005 Rational selection of structurally diverse natural product scaffolds with favorable ADME properties for drug discovery Mol Divers 9 1-3 131 139 1:CAS:528:DC%2BD2MXhslelsLw%3D 10.1007/s11030-005-1297-7 15789560 (Pubitemid 40394847)
-
(2005)
Molecular Diversity
, vol.9
, Issue.1-3
, pp. 131-139
-
-
Samiulla, D.S.1
Vaidyanathan, V.V.2
Arun, P.C.3
Balan, G.4
Blaze, M.5
Bondre, S.6
Chandrasekhar, G.7
Gadakh, A.8
Kumar, R.9
Kharvi, G.10
Kim, H.-O.11
Kumar, S.12
Malikayil, J.A.13
Moger, M.14
Mone, M.K.15
Nagarjuna, P.16
Ogbu, C.17
Pendhalkar, D.18
Raja Rao, A.V.S.19
Venkateshwar Rao, G.20
Sarma, V.K.21
Shaik, S.22
Sharma, G.V.R.23
Singh, S.24
Sreedhar, C.25
Sonawane, R.26
Timmanna, U.27
Hardy, L.W.28
more..
-
24
-
-
0032518454
-
A general pattern for substrate recognition by P-glycoprotein
-
DOI 10.1046/j.1432-1327.1998.2510252.x
-
A Seelig 1998 A general pattern for substrate recognition by P-glycoprotein Eur J Biochem 251 1-2 252 261 1:CAS:528:DyaK1cXnvV2rsg%3D%3D 10.1046/j.1432-1327.1998.2510252.x 9492291 (Pubitemid 28081437)
-
(1998)
European Journal of Biochemistry
, vol.251
, Issue.1-2
, pp. 252-261
-
-
Seelig, A.1
-
26
-
-
0022870696
-
Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells
-
1:CAS:528:DyaL2sXktFOgtb0%3D 10.1007/BF00173503 3583642
-
RT Dorr JD Liddil MJ Soble 1986 Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells Invest New Drugs 4 4 305 313 1:CAS:528:DyaL2sXktFOgtb0%3D 10.1007/BF00173503 3583642
-
(1986)
Invest New Drugs
, vol.4
, Issue.4
, pp. 305-313
-
-
Dorr, R.T.1
Liddil, J.D.2
Soble, M.J.3
-
27
-
-
1842535990
-
Classification analysis of P-glycoprotein substrate specificity
-
DOI 10.1080/10611860310001648248
-
R Didziapetris P Japertas A Avdeef A Petrauskas 2003 Classification analysis of P-glycoprotein substrate specificity J Drug Target 11 7 391 406 1:CAS:528:DC%2BD2cXjtFOjs7k%3D 10.1080/10611860310001648248 15203928 (Pubitemid 38455825)
-
(2003)
Journal of Drug Targeting
, vol.11
, Issue.7
, pp. 391-406
-
-
Didziapetris, R.1
Japertas, P.2
Avdeef, A.3
Petrauskas, A.4
-
28
-
-
0028030228
-
Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen
-
1:CAS:528:DyaK2MXitVantbw%3D 7969041
-
JS Lee K Paull M Alvarez C Hose A Monks M Grever, et al. 1994 Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen Mol Pharmacol 46 4 627 638 1:CAS:528:DyaK2MXitVantbw%3D 7969041
-
(1994)
Mol Pharmacol
, vol.46
, Issue.4
, pp. 627-638
-
-
Lee, J.S.1
Paull, K.2
Alvarez, M.3
Hose, C.4
Monks, A.5
Grever, M.6
-
29
-
-
0343306779
-
Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein
-
DOI 10.1021/bi9718043
-
M Essodaigui HJ Broxterman A Garnier-Suillerot 1998 Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein Biochemistry 37 8 2243 2250 1:CAS:528:DyaK1cXotFGmtw%3D%3D 10.1021/bi9718043 9485370 (Pubitemid 28119297)
-
(1998)
Biochemistry
, vol.37
, Issue.8
, pp. 2243-2250
-
-
Essodaigui, M.1
Broxterman, H.J.2
Garnier-Suillerot, A.3
-
30
-
-
0033739115
-
Structure-activity relationship of P-glycoprotein substrates and modifiers
-
1:CAS:528:DC%2BD3cXot1yiu7w%3D 10.1016/S0928-0987(00)00177-9 11121731
-
A Seelig E Landwojtowicz 2000 Structure-activity relationship of P-glycoprotein substrates and modifiers Eur J Pharm Sci 12 1 31 40 1:CAS:528:DC%2BD3cXot1yiu7w%3D 10.1016/S0928-0987(00)00177-9 11121731
-
(2000)
Eur J Pharm Sci
, vol.12
, Issue.1
, pp. 31-40
-
-
Seelig, A.1
Landwojtowicz, E.2
-
31
-
-
0033669437
-
Prediction of drug transport processes using simple parameters and PLS statistics. the use of ACD/logP and ACD/ChemSketch descriptors
-
1:CAS:528:DC%2BD3cXoslGhtbk%3D 10.1016/S0928-0987(00)00189-5 11113652
-
T Osterberg U Norinder 2001 Prediction of drug transport processes using simple parameters and PLS statistics. The use of ACD/logP and ACD/ChemSketch descriptors Eur J Pharm Sci 12 3 327 337 1:CAS:528:DC%2BD3cXoslGhtbk%3D 10.1016/S0928-0987(00)00189-5 11113652
-
(2001)
Eur J Pharm Sci
, vol.12
, Issue.3
, pp. 327-337
-
-
Osterberg, T.1
Norinder, U.2
-
32
-
-
14644419054
-
Functional role of P-glycoprotein in limiting intestinal absorption of drugs: Contribution of passive permeability to P-glycoprotein mediated efflux transport
-
DOI 10.1021/mp0499196
-
MV Varma K Sateesh R Panchagnula 2005 Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport Mol Pharmacol 2 1 12 21 1:CAS:528:DC%2BD2cXhtVSmu7vF 10.1021/mp0499196 (Pubitemid 40314725)
-
(2005)
Molecular Pharmaceutics
, vol.2
, Issue.1
, pp. 12-21
-
-
Varma, M.V.S.1
Sateesh, K.2
Panchagnula, R.3
-
33
-
-
29244485123
-
Interactions between the dopamine agonist, bromocriptine and the efflux protein, P-glycoprotein at the blood-brain barrier in the mouse
-
DOI 10.1016/j.ejps.2005.09.009, PII S0928098705002824
-
S Vautier L Lacomblez H Chacun V Picard F Gimenez R Farinotti, et al. 2006 Interactions between the dopamine agonist, bromocriptine and the efflux protein, P-glycoprotein at the blood-brain barrier in the mouse Eur J Pharm Sci 27 2-3 167 174 1:CAS:528:DC%2BD2MXhtlCktbfP 10.1016/j.ejps.2005.09.009 16263252 (Pubitemid 41831252)
-
(2006)
European Journal of Pharmaceutical Sciences
, vol.27
, Issue.2-3
, pp. 167-174
-
-
Vautier, S.1
Lacomblez, L.2
Chacun, H.3
Picard, V.4
Gimenez, F.5
Farinotti, R.6
Fernandez, C.7
-
34
-
-
0031863588
-
P-glycoprotein-mediated transport of itraconazole across the blood- brain barrier
-
T Miyama H Takanaga H Matsuo K Yamano K Yamamoto T Iga, et al. 1998 P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier Antimicrob Agents Chemother 42 7 1738 1744 1:CAS:528:DyaK1cXktlKgsrg%3D 9661014 (Pubitemid 28311572)
-
(1998)
Antimicrobial Agents and Chemotherapy
, vol.42
, Issue.7
, pp. 1738-1744
-
-
Miyama, T.1
Takanaga, H.2
Matsuo, H.3
Yamano, K.4
Yamamoto, K.5
Iga, T.6
Naito, M.7
Tsuruo, T.8
Ishizuka, H.9
Kawahara, Y.10
Sawada, Y.11
-
35
-
-
0031936939
-
Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin
-
1:CAS:528:DyaK1cXhtlSmsbs%3D 9516927
-
E Mechetner A Kyshtoobayeva S Zonis H Kim R Stroup R Garcia, et al. 1998 Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin Clin Cancer Res 4 2 389 398 1:CAS:528:DyaK1cXhtlSmsbs%3D 9516927
-
(1998)
Clin Cancer Res
, vol.4
, Issue.2
, pp. 389-398
-
-
Mechetner, E.1
Kyshtoobayeva, A.2
Zonis, S.3
Kim, H.4
Stroup, R.5
Garcia, R.6
-
36
-
-
33644755350
-
Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer
-
DOI 10.1016/j.canlet.2005.05.052, PII S0304383505009286, Pharmacogenomics in Cancer Chemotherapy: Recent Advances in Drug Transporters and Genome Analysis
-
H Nakagawa H Saito Y Ikegami S Aida-Hyugaji S Sawada T Ishikawa 2006 Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer Cancer Lett 234 1 81 89 1:CAS:528:DC%2BD28Xit12itb8%3D 10.1016/j.canlet.2005.05.052 16309825 (Pubitemid 43343942)
-
(2006)
Cancer Letters
, vol.234
, Issue.1
, pp. 81-89
-
-
Nakagawa, H.1
Saito, H.2
Ikegami, Y.3
Aida-Hyugaji, S.4
Sawada, S.5
Ishikawa, T.6
-
37
-
-
33750478648
-
Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter
-
DOI 10.1038/sj.bjp.0706904, PII 0706904
-
R Clark ID Kerr R Callaghan 2006 Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter Br J Pharmacol 149 5 506 515 1:CAS:528:DC%2BD28XhtFeru7vO 10.1038/sj.bjp.0706904 16981002 (Pubitemid 44658511)
-
(2006)
British Journal of Pharmacology
, vol.149
, Issue.5
, pp. 506-515
-
-
Clark, R.1
Kerr, I.D.2
Callaghan, R.3
-
38
-
-
22244441801
-
Direct liquid chromatography determination of the reactive imine SJG-136 (NSC 694501)
-
1:CAS:528:DC%2BD2MXmsVOnurY%3D 15994138
-
A Cheung E Struble J He C Yang E Wang DE Thurston, et al. 2005 Direct liquid chromatography determination of the reactive imine SJG-136 (NSC 694501) J Chromatogr B Analyt Technol Biomed Life Sci 822 1-2 10 20 1:CAS:528: DC%2BD2MXmsVOnurY%3D 15994138
-
(2005)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.822
, Issue.12
, pp. 10-20
-
-
Cheung, A.1
Struble, E.2
He, J.3
Yang, C.4
Wang, E.5
Thurston, D.E.6
-
39
-
-
0036644903
-
Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918
-
DOI 10.1200/JCO.2002.12.116
-
CM Kruijtzer JH Beijnen H Rosing 2002 ten Bokkel Huinink WW, Schot M, Jewell RC, et al. Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918 J Clin Oncol 20 13 2943 2950 1:CAS:528:DC%2BD38Xlslyrt7w%3D 10.1200/JCO.2002.12. 116 12089223 (Pubitemid 34728888)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.13
, pp. 2943-2950
-
-
Kruijtzer, C.M.F.1
Beijnen, J.H.2
Rosing, H.3
Ten Bokkel Huinink, W.W.4
Schot, M.5
Jewell, R.C.6
Paul, E.M.7
Schellens, J.H.M.8
-
40
-
-
0035992230
-
Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase i clinical study
-
1:CAS:528:DC%2BD38XmtVWit7s%3D 12114401
-
HM McDaid S Mani HJ Shen F Muggia D Sonnichsen SB Horwitz 2002 Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical study Clin Cancer Res 8 7 2035 2043 1:CAS:528: DC%2BD38XmtVWit7s%3D 12114401
-
(2002)
Clin Cancer Res
, vol.8
, Issue.7
, pp. 2035-2043
-
-
McDaid, H.M.1
Mani, S.2
Shen, H.J.3
Muggia, F.4
Sonnichsen, D.5
Horwitz, S.B.6
-
41
-
-
3342880864
-
ABCG2 mediates differential resistance to SN-38 (7-ethyl-10- hydroxycamptothecin) and homocamptothecins
-
DOI 10.1124/jpet.103.063149
-
SE Bates WY Medina-Perez G Kohlhagen S Antony T Nadjem RW Robey, et al. 2004 ABCG2 mediates differential resistance to SN-38 (7-ethyl-10- hydroxycamptothecin) and homocamptothecins J Pharmacol Exp Ther 310 2 836 842 1:CAS:528:DC%2BD2cXmtVykt7g%3D 10.1124/jpet.103.063149 15075385 (Pubitemid 38988932)
-
(2004)
Journal of Pharmacology and Experimental Therapeutics
, vol.310
, Issue.2
, pp. 836-842
-
-
Bates, S.E.1
Medina-Perez, W.Y.2
Kohlhagen, G.3
Antony, S.4
Nadjem, T.5
Robey, R.W.6
Pommier, Y.7
|